Immunoengineering: How Nanotechnology Can Enhance Cancer Immunotherapy
Cet article passe en revue les perspectives offertes par les nanotechnologies pour améliorer l'efficacité des immunothérapies anticancéreuses
Although cancer immunotherapy can lead to durable outcomes, the percentage of patients who respond to this disruptive approach remains modest to date. Encouragingly, nanotechnology can enhance the efficacy of immunostimulatory small molecules and biologics by altering their co-localization, biodistribution, and release kinetics.